255 related articles for article (PubMed ID: 22030324)
1. Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord.
Marshall TM; Herman DS; Largent-Milnes TM; Badghisi H; Zuber K; Holt SC; Lai J; Porreca F; Vanderah TW
Pain; 2012 Jan; 153(1):86-94. PubMed ID: 22030324
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.
Xie JY; Herman DS; Stiller CO; Gardell LR; Ossipov MH; Lai J; Porreca F; Vanderah TW
J Neurosci; 2005 Jan; 25(2):409-16. PubMed ID: 15647484
[TBL] [Abstract][Full Text] [Related]
3. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat.
Kovelowski CJ; Ossipov MH; Sun H; Lai J; Malan TP; Porreca F
Pain; 2000 Sep; 87(3):265-273. PubMed ID: 10963906
[TBL] [Abstract][Full Text] [Related]
4. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors.
Dogrul A; Ossipov MH; Porreca F
Brain Res; 2009 Jul; 1280():52-9. PubMed ID: 19427839
[TBL] [Abstract][Full Text] [Related]
5. Rostral ventromedial medulla-mediated descending facilitation following P2X7 receptor activation is involved in the development of chronic post-operative pain.
Wang W; Zhong X; Li Y; Guo R; Du S; Wen L; Ying Y; Yang T; Wei XH
J Neurochem; 2019 Jun; 149(6):760-780. PubMed ID: 30570747
[TBL] [Abstract][Full Text] [Related]
6. Loss of neurons in rostral ventromedial medulla that express neurokinin-1 receptors decreases the development of hyperalgesia.
Khasabov SG; Simone DA
Neuroscience; 2013 Oct; 250():151-65. PubMed ID: 23831426
[TBL] [Abstract][Full Text] [Related]
7. Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla.
Lagraize SC; Guo W; Yang K; Wei F; Ren K; Dubner R
Neuroscience; 2010 Dec; 171(4):1341-56. PubMed ID: 20888891
[TBL] [Abstract][Full Text] [Related]
8. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.
Heinricher MM; McGaraughty S; Tortorici V
J Neurophysiol; 2001 Jan; 85(1):280-6. PubMed ID: 11152727
[TBL] [Abstract][Full Text] [Related]
9. The dorsomedial hypothalamus mediates stress-induced hyperalgesia and is the source of the pronociceptive peptide cholecystokinin in the rostral ventromedial medulla.
Wagner KM; Roeder Z; Desrochers K; Buhler AV; Heinricher MM; Cleary DR
Neuroscience; 2013 May; 238():29-38. PubMed ID: 23415792
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Wang CT; Mao CJ; Zhang XQ; Zhang CY; Lv DJ; Yang YP; Xia KL; Liu JY; Wang F; Hu LF; Xu GY; Liu CF
Mol Pain; 2017 Jan; 13():1744806917691525. PubMed ID: 28326933
[TBL] [Abstract][Full Text] [Related]
11. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation.
Gardell LR; Vanderah TW; Gardell SE; Wang R; Ossipov MH; Lai J; Porreca F
J Neurosci; 2003 Sep; 23(23):8370-9. PubMed ID: 12967999
[TBL] [Abstract][Full Text] [Related]
12. Hyperalgesia and sensitization of dorsal horn neurons following activation of NK-1 receptors in the rostral ventromedial medulla.
Khasabov SG; Malecha P; Noack J; Tabakov J; Giesler GJ; Simone DA
J Neurophysiol; 2017 Nov; 118(5):2727-2744. PubMed ID: 28794197
[TBL] [Abstract][Full Text] [Related]
13. Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain.
Wei F; Dubner R; Zou S; Ren K; Bai G; Wei D; Guo W
J Neurosci; 2010 Jun; 30(25):8624-36. PubMed ID: 20573908
[TBL] [Abstract][Full Text] [Related]
14. Participation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mustard oil.
Urban MO; Jiang MC; Gebhart GF
Brain Res; 1996 Oct; 737(1-2):83-91. PubMed ID: 8930354
[TBL] [Abstract][Full Text] [Related]
15. Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla.
Heinricher MM; Neubert MJ
J Neurophysiol; 2004 Oct; 92(4):1982-9. PubMed ID: 15152023
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 in the midbrain periaqueductal gray produces hyperalgesia and activates pain-modulating circuitry in the rostral ventromedial medulla.
Heinricher MM; Martenson ME; Neubert MJ
Pain; 2004 Jul; 110(1-2):419-26. PubMed ID: 15275794
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.
Burgess SE; Gardell LR; Ossipov MH; Malan TP; Vanderah TW; Lai J; Porreca F
J Neurosci; 2002 Jun; 22(12):5129-36. PubMed ID: 12077208
[TBL] [Abstract][Full Text] [Related]
18. Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptors.
Zhang W; Gardell S; Zhang D; Xie JY; Agnes RS; Badghisi H; Hruby VJ; Rance N; Ossipov MH; Vanderah TW; Porreca F; Lai J
Brain; 2009 Mar; 132(Pt 3):778-87. PubMed ID: 19050032
[TBL] [Abstract][Full Text] [Related]
19. Descending facilitation maintains long-term spontaneous neuropathic pain.
Wang R; King T; De Felice M; Guo W; Ossipov MH; Porreca F
J Pain; 2013 Aug; 14(8):845-53. PubMed ID: 23602267
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.
Porreca F; Burgess SE; Gardell LR; Vanderah TW; Malan TP; Ossipov MH; Lappi DA; Lai J
J Neurosci; 2001 Jul; 21(14):5281-8. PubMed ID: 11438603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]